Omnia Family Wealth, LLC Vertex Pharmaceuticals Inc Transaction History

Omnia Family Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $4,115 - $4,759	-25 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $4,093 - $4,867	25 New	25 $5,000
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $2,622 - $3,059	-18 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $2,728 - $3,188	18 New	18 $3,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Omnia Family Wealth, LLC with notifications on news.